Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early Type 2 diabetes
Year: 1998
Type: article
Source: Clinical Science
DOI: 10.1042/cs0950325
Institutions: Hammersmith Hospital, Ealing Hospital NHS Trust
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Eli Lilly and Company, Wellcome Trust
OpenAlex ID: W2080045468
